These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3440029)
21. [Metabolism of vincamine in the rat]. Viganò V; Paracchini S; Piacenza G; Pesce E Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256 [TBL] [Abstract][Full Text] [Related]
22. Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide in rats: evidence for bioactivation through alcohol-O-glucuronidation and O-sulfation. Cui D; Rankin GO; Harvison PJ Chem Res Toxicol; 2005 Jun; 18(6):991-1003. PubMed ID: 15962934 [TBL] [Abstract][Full Text] [Related]
23. Serum protein binding of penbutolol in patients with hepatic cirrhosis. Aguirre C; Calvo R; Rodríguez Sasiaín JM Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):566-9. PubMed ID: 3243661 [TBL] [Abstract][Full Text] [Related]
24. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro]. Honma S; Ito T; Matsuki Y Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088 [No Abstract] [Full Text] [Related]
25. In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. Nicoll-Griffith DA; Seto C; Aubin Y; Lévesque JF; Chauret N; Day S; Silva JM; Trimble LA; Truchon JF; Berthelette C; Lachance N; Wang Z; Sturino C; Braun M; Zamboni R; Young RN Bioorg Med Chem Lett; 2007 Jan; 17(2):301-4. PubMed ID: 17095220 [TBL] [Abstract][Full Text] [Related]
26. Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations. Meyer BH; Müller FO; Hundt HK; Grigoleit HG; Hajdu P; Heptner W S Afr Med J; 1981 Jun; 59(25):891-3. PubMed ID: 7015536 [TBL] [Abstract][Full Text] [Related]
27. Mass spectral characterization of the glucuronide conjugates of terbutryn (2-(t-butylamino)-4-(ethylamino)-6-(methylthio)-s-triazine) metabolites from rats and goat. Larsen GH; Bakke JE Biomed Mass Spectrom; 1978 Jun; 5(6):391-4. PubMed ID: 678608 [TBL] [Abstract][Full Text] [Related]
28. Selective isolation of in vitro phase II conjugates using a lipophilic anionic exchange solid phase extraction method. Gagné S; Laterreur J; Mahrouche L; Sørensen D; Gauthier JY; Truong VL; Chauret N; Lévesque JF J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 863(2):242-8. PubMed ID: 18262477 [TBL] [Abstract][Full Text] [Related]
29. Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog. Wikberg T; Taskinen J Drug Metab Dispos; 1993; 21(2):325-33. PubMed ID: 8097704 [TBL] [Abstract][Full Text] [Related]
30. Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes. Sundheimer DW; Brendel K Drug Metab Dispos; 1983; 11(5):433-40. PubMed ID: 6138228 [TBL] [Abstract][Full Text] [Related]
31. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851 [TBL] [Abstract][Full Text] [Related]
32. Direct detection of boldenone sulfate and glucuronide conjugates in horse urine by ion trap liquid chromatography-mass spectrometry. Pu F; McKinney AR; Stenhouse AM; Suann CJ; McLeod MD J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):241-6. PubMed ID: 15556539 [TBL] [Abstract][Full Text] [Related]
33. Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test. Zheng M; McErlane KM; Ong MC Life Sci; 2004 Nov; 75(26):3129-46. PubMed ID: 15488893 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of N-acetylcysteine conjugates of valproic acid in humans and animals. Gopaul SV; Farrell K; Abbott FS Drug Metab Dispos; 2000 Jul; 28(7):823-32. PubMed ID: 10859157 [TBL] [Abstract][Full Text] [Related]
35. [Isolation and identification of metabolites of 5-ethyl-2'-deoxyuridine from rat urine]. Kaul R; Hempel B Arzneimittelforschung; 1985; 35(7):1055-7. PubMed ID: 4052140 [TBL] [Abstract][Full Text] [Related]
36. Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulfur detection. Corcoran O; Nicholson JK; Lenz EM; Abou-Shakra F; Castro-Perez J; Sage AB; Wilson ID Rapid Commun Mass Spectrom; 2000; 14(24):2377-84. PubMed ID: 11114054 [TBL] [Abstract][Full Text] [Related]
37. Excretion of metabolites in urine and faeces from rats dosed with the heterocyclic amine, 2-amino-9H-pyrido[2,3-b]indole (AalphaC). Frederiksen H; Frandsen H Food Chem Toxicol; 2004 Jun; 42(6):879-85. PubMed ID: 15110096 [TBL] [Abstract][Full Text] [Related]
38. Identification of clozapine N(+)-glucuronide in the urine of patients treated with clozapine using electrospray mass spectrometry. Luo H; McKay G; Midha KK Biol Mass Spectrom; 1994 Mar; 23(3):147-8. PubMed ID: 8148405 [TBL] [Abstract][Full Text] [Related]
39. Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals. Pfadenhauer EH; Bankert CS; Jensen J; Jones CE; Jenkins EE; McCloskey JA Drug Metab Dispos; 1984; 12(3):280-4. PubMed ID: 6145553 [TBL] [Abstract][Full Text] [Related]